Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
06/2000
06/22/2000WO2000036093A2 Intein-mediated cyclization of peptides
06/22/2000WO2000035945A1 Cyclic peptide antifungal agents having a sugar substituent
06/22/2000WO2000035944A1 Cyclic peptide antifungal agents
06/22/2000WO2000035943A1 Halovir, an antiviral marine natural product, and derivatives thereof
06/22/2000WO2000035887A2 Vitronectin receptor antagonist pharmaceuticals
06/22/2000WO2000035407A2 Inhibition of angiogenesis by high molecular weight kininogen domain 3 peptide analogs
06/22/2000WO2000012709A3 Phelix: a testis-specific protein expressed in cancer
06/22/2000WO2000011029A3 Novel anti-diabetic peptides
06/22/2000WO1999059615A9 Hybrid polypeptides with enhanced pharmacokinetic properties
06/22/2000CA2355934A1 Intein mediated cyclization of peptides
06/22/2000CA2355287A1 Inhibition of angiogenesis by high molecular weight kininogen domain 3 peptide analogs
06/22/2000CA2354451A1 Halovir, an antiviral marine natural product, and derivatives thereof
06/22/2000CA2354056A1 Cyclic peptide antifungal agents
06/22/2000CA2354055A1 Cyclic peptide antifungal agents having a sugar substituent
06/22/2000CA2353072A1 Metallopeptide combinatorial libraries and applications
06/22/2000CA2349333A1 Vitronectin receptor antagonist pharmaceuticals
06/21/2000EP1009819A1 Methods using phage display for selecting internalizing ligands for gene delivery
06/21/2000EP1009771A1 Peptides which elicit cytotoxic t cellular immunity
06/21/2000EP1009726A1 Fluorination of proteins and peptides for f-18 positron emission tomography
06/21/2000EP1009420A1 Conjugates useful in the treatment of prostate cancer
06/21/2000CN1257539A Short peptides which selectively modulate intracellular signalling
06/21/2000CN1257538A Short peptides which selectively modulate the activity of serine/threonine kinases
06/21/2000CN1257510A New BPC peptide salts with organo-protective activity, the process for their preparation and their use in therapy
06/21/2000CN1053699C Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
06/20/2000US6077934 Contryphan peptides
06/20/2000US6077706 Helicobacter pylori proteins useful for vaccines and diagnostics
06/20/2000US6077699 Purified nucleotide sequence of orf1 gene of streptomyces pristinaespiralis or its complement; for recombinant production of known and novel antibiotics
06/20/2000US6077679 Herpes virus proteinase and method of assaying
06/20/2000CA1341032C Anticoagulant peptides
06/20/2000CA1341030C Protein active in humoral hypercalcemia of malignancy-pthrp
06/20/2000CA1341029C Peptidase inhibitors
06/15/2000WO2000034452A1 Glucoamylases with n-terminal extensions
06/15/2000WO2000034315A2 Purification of echinocandin cyclopeptide compounds
06/15/2000WO2000034308A2 Protein transduction system and methods of use thereof
06/15/2000WO2000034236A1 REVERSIBLE AQUEOUS pH SENSITIVE LIPIDIZING REAGENTS, COMPOSITIONS AND METHODS OF USE
06/15/2000WO2000033888A2 Prodrug compounds and process for preparation thereof
06/15/2000WO2000011023A3 Ring modified cyclic peptide analogs
06/15/2000WO2000009711A3 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE α1/β1 (hsGCα1/β1)
06/15/2000WO2000006604A3 Use of cd25 binding molecules in the treatment of rheumatoid arthritis or skin diseases
06/15/2000WO2000005254A3 Novel peptides for use in immunotherapy of autoimmune diseases
06/15/2000WO1999002550A8 Ctl epitopes from ebv
06/15/2000CA2354766A1 Prodrug compounds and process for preparation thereof
06/15/2000CA2354142A1 Reversible aqueous ph sensitive lipidizing reagents, compositions and methods of use
06/15/2000CA2354044A1 Protein transduction system and methods of use thereof
06/15/2000CA2353930A1 Purification of echinocandin cyclopeptide compounds
06/15/2000CA2352046A1 Glucoamylases with n-terminal extensions
06/14/2000EP1008656A1 Process for producing lh-rh derivatives
06/14/2000EP1007729A1 COMPLEX FORMATION BETWEEN dsDNA AND OLIGOMER OF HETEROCYCLES
06/14/2000EP1007699A1 Peptide-enhanced transfections
06/14/2000EP1007566A2 Therapeutic use of the smr1 protein and active derivatives thereof
06/14/2000EP1007561A2 Novel conjugates of opioids and endogenous carriers
06/14/2000EP1007547A1 Peptides comprising a t-cell epitope specific to collagen ii
06/14/2000EP1007095A2 Chimeric toxins for targeted therapy
06/14/2000EP1007081A1 Universal t-cell epitopes for anti-malarial vaccines
06/14/2000EP1007079A1 Identification of broadly reactive dr restricted epitopes
06/14/2000EP1007078A1 Peptidomimetics containing 6-peptidylamino-1-naphthalenesulfonamide moieties
06/14/2000EP1007076A1 Method of antagonizing the human src sh2 domain
06/14/2000EP1006785A1 Antimicrobial proteins
06/14/2000EP0710243B1 Synthesis of cyclic peptides
06/14/2000EP0677057B1 Biopolymer synthesis utilizing surface activated, organic polymers
06/14/2000CN1256628A Sustained-release compositions and method for preparing same
06/14/2000CN1053451C Novel peptide compound with therapeutic active in blood coagulation reaction, its prep. and pharmaceutical composition thereof
06/13/2000US6075129 Anticoagulent peptide; for use in inhibiting or facilitating inhibition of platelet aggregation
06/13/2000US6075122 A peptide for the detection, monitoring, and treatment of cancer in animals; anticarciongenic agents
06/13/2000US6075121 Modified peptide and peptide libraries with protease resistance, derivatives thereof and methods of producing and screening such
06/13/2000US6075120 Bradykinin antagonist
06/13/2000US6075006 For treatment of arthritis, asthma, inflammation, tumoral growth, gastro intestinal hypermotility, huntington disease, neuritis, neuralgia, migraine, hypertension, incontinence of urine, urticaria, symptoms of the carcinoid syndrome
06/13/2000US6074662 Proteinaceous animal chew with dentally therapeutic cation
06/13/2000US6074650 Membrane anchor/active compound conjugate, its preparation and its uses
06/13/2000CA2157196C Inhibitors of herpes viral ribonucleotide reductase
06/13/2000CA2137072C Conformationally restrained peptide analogs as antiplatelet agents
06/13/2000CA2077537C Therapeutically useful peptides and peptide fragments
06/13/2000CA1341022C Prepro-lhrh c-terminal peptide
06/09/2000CA2286312A1 Peptide fragments derived from cwpm23, a protein involved in freezing resistance of winter wheat
06/08/2000WO2000032794A2 Chlamydia antigens and corresponding dna fragments and uses thereof
06/08/2000WO2000032769A2 Mage-10 or mage-8 derived hla-a2.1-binding oligopeptides
06/08/2000WO2000032759A1 Human plasminogen activator
06/08/2000WO2000032629A2 Antiviral peptides
06/08/2000WO2000032237A1 Pharmaceutical composition comprising an anti-cancer agent and at least a peptide
06/08/2000WO2000032228A2 Peptide-based vaccine for influenza
06/08/2000WO2000032218A1 Controlled release formulation comprising gnrh-ii
06/08/2000WO1999024076A9 Salicylate derivatized therapeutic and diagnostic agents
06/08/2000CA2353798A1 Controlled release formulation comprising gnrh-ii
06/08/2000CA2353699A1 Human plasminogen activator
06/08/2000CA2353530A1 Antiviral peptides
06/08/2000CA2352759A1 Chlamydia antigens and corresponding dna fragments and uses thereof
06/08/2000CA2352454A1 Peptide-based vaccine for influenza
06/08/2000CA2352134A1 Pharmaceutical composition comprising an anti-cancer agent and at least a peptide
06/07/2000EP1006126A2 Osteogenic peptides
06/07/2000EP1005484A1 Compounds with growth hormone releasing properties
06/07/2000EP1005330A1 Methods and compositions for targeting compounds to muscle
06/07/2000EP1005274A1 Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes
06/06/2000US6072045 Chimeric isoprenoid synthases and uses thereof
06/06/2000US6072039 Hybrid polypeptide comparing a biotinylated avidin binding polypeptide fused to a polypeptide of interest
06/06/2000US6071881 A peptide havig growth promotion effects and activity promotion effects on osteoblasts
06/06/2000US6071879 Method for the treatment of bacterial infection
06/06/2000US6071730 Cell ablation using trans-splicing ribozymes
06/06/2000US6071710 Antikinin compounds and uses thereof
06/06/2000CA2132547C Vaccines containing non-ionic surfactant vesicles
06/02/2000WO2000031291A1 Method for screening for substances which are activators, inhibitors or binders of pkb by the use of a substrate peptide and the use of the substrate peptide
1 ... 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 ... 423